Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New therapy for neurodegenerative diseases


MBM ScienceBridge GmbH, Georg-August-University Göttingen, University Medical Center and MRC Technology a UK medical research charity, are collaborating on new therapy for neurodegenerative diseases.

MBM ScienceBridge GmbH, Georg-August-University Göttingen, University Medical Center and MRC Technology, a UK medical research charity, have signed an exclusive license agreements for the development of a novel therapy of neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x. The aim is to develop a therapy for Alzheimer's Disease (AD).

The licence negotiated by MBM ScienceBridge GmbH, the technology transfer organization of the Georg-August-Universität Göttingen, will enable UMG to access the world-class antibody humanization expertise of MRCT’s Centre for Therapeutics Discovery and the work of its Therapeutic Antibody Group, led by Dr David Matthews and gives MRCT the opportunity to use its renowned capability to take lab tool compounds and turn them into clinical candidates, which will then be licensed to the pharmaceutical and biotech industry.

MRCT receives an exclusive worldwide license to the IP rights of UMG related to a novel therapeutic approach for the treatment of sporadic and familial AD, based on a panel of unique antibodies developed by its scientist Prof. Dr. Thomas Bayer. MRCT and UMG will then receive downstream payments dependent on the successful development and out-licensing of the antibody. This income will be used for further research within the organisations.

Notes to Editors

Media Contacts:
MBM ScienceBridge GmbH
E-mail:, Phone: +49-551-30724150

MRC Technology
Liezel Tipper PR & Communications Manager, MRC Technology
E-mail:, Phone: +44(0) 20 7391 2772

About Alzheimer's Disease
The occurence of Alzheimer's Disease is estimated at 5% of people between 65 to 75 years of age, and at 24% of persons over the age of 85 years. It is the most frequendt type of dementia in elderly people. The prevalence of alzheimer's Disease is estimated at 2.2% among the populations of the seven major markets of USA, Japan, UK, Germany, France, Italy & Spain. The increasing aging population particularly in countries like China or Brazil, will dramatically increase the total number of patients. The lack of efficacious drugs implies high growth potential, shaping a competitive and dynamic therapeutic area. Revenues forecast these markets are of several US$ billions a year, having experienced formidable growth.

About MBM ScienceBridge GmbH
The MBM ScienceBridge GmbH is a fully owned subsidiary of the University of Göttingen and acts on its behalf as a technology transfer interface to companies around the world. The IP portfolio managed by MBM ScienceBridge covers innovation in the areas of Life Sciences, Chemistry, Physics, Optics, Agriculture, Forestry and Medical Technologies.
Contact:,, +49-551-30724151.

About Georg-August-University Göttingen
The Georg-August-Universität Göttingen, Universitätsmedizin, Germany, was founded in 1737 in the spirit of the Enlightenment, which laid and continues to laythe foundation - both in the natural sciences and in the humanities - for the present day University's excellent reputation.

About MRC Technology
MRCT ( is an independent life science medical research charity, offering professional services to organisations within the academic, charity, biotechnology and pharmaceutical sectors globally. Services include IP management and research and development for diagnostics, small molecules and therapeutic antibodies. MRC Technology bridges the gap between basic medical research and commercialisation, helping early discoveries progress to clinical application. Four of MRC Technology’s projects have led to approved drugs (Tysabri®, Actemra®, Entyvio®, Keytruda®) and the company has a strong pipeline in development.

Stefan Weller | idw - Informationsdienst Wissenschaft
Further information:

More articles from Life Sciences:

nachricht Gene therapy shows promise for treating Niemann-Pick disease type C1
27.10.2016 | NIH/National Human Genome Research Institute

nachricht 'Neighbor maps' reveal the genome's 3-D shape
27.10.2016 | International School of Advanced Studies (SISSA)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>